Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07847281 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of AK157D1 for Injection in Advanced Solid Tumors

StatusNot Yet Recruiting
PhasePhase 1
SponsorAkeso
Started2026-09-21
View on ClinicalTrials.gov ↗
96 trials monitored
See 1 trial at risk
This is an first-in-human, Phase I clinical study aimed at evaluating the safety, tolerability, PK, immunogenicity, and preliminary antitumor efficacy of AK157D1 for injection in advanced solid tumors.
Trial Details
NCT Number NCT07847281
Lead Sponsor Akeso
Conditions Advanced Solid Tumors
Enrollment 243 participants
Start Date 2026-09-21
Primary Completion 2029-03-30 (estimated)
Study Completion 2029-09-15 (estimated)
Updated on ClinicalTrials.gov 2026-09-29